News & Events
Sep 24, 2018
CathWorks FFRangio™ System files FDA 510(k) submission.
CathWorks announced that it has submitted its CathWorks FFRangio™ System to the United States Food & Drug Administration (FDA) for review and 510(k) market clearance.
Aug 15, 2018
CathWorks Fast-FFR trial enrollment completed early.
CathWorks announced that its FAST-FFR trial is fully enrolled ahead of schedule. The trial is designed to evaluate efficacy of the CathWorks FFRangio™ System in terms of sensitivity and specificity when compared to conventional invasive Fractional Flow Reserve (FFR).
Sep 24, 2018 – San Diego, CA
Lunch Presentation Theater Program
FFRangio for PCI Guidance:
A Clinical Review